Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.65
+0.43 (2.65%)
At close: Oct 9, 2026, 4:00 PM EDT
16.71
+0.06 (0.37%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $2.22 billion as of October 9, 2026. It is the 6,340th most valuable company in the world and the 1,707th biggest in the United States. Its market cap has increased by 45.96% in one year.
Market Cap
2.22B
Enterprise Value
1.84B
1-Year Change
45.96%
Global Rank
Country Rank
#1,707 United States
Category
ChartMarket Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $2.22B, an increase of 1,665.18%. That is a compound annual growth rate of 26.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.22B | 5.35% |
| Dec 31, 2025 | 2.10B | 63.56% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
| Sep 3, 2014 | 125.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 2.41B |
| Nurix Therapeutics | 2.40B |
| Celldex Therapeutics | 2.35B |
| SELLAS Life Sciences Group | 2.35B |
| Harmony Biosciences Holdings | 2.35B |
| ADMA Biologics | 2.31B |
| Recursion Pharmaceuticals | 2.29B |
| Immunome | 2.23B |